Bids for Indian pharma giant turn hostile
The acquisition of India’s biggest drug maker, Ranbaxy, by Japanese pharmaceutical company, Daiichi Sankyo, has been thrown into some doubt amid rumours of a hostile takeover bid for the generic company from Pfizer.
The agreement, made last week…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.